Dealmaking with Pharma's Middle Tier
Some 200 US biotech and European pharmaceutical execs-most of the latter from mid-sized drug firms like Servier, Recordati, Asta Medica, Schwarz and Almirall-gathered in Paris, June 16-18 for the third annual Euro-Biotech conference. Here we look atsome reports of key speakers at the conference.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.